Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
12 Setembro 2023 - 5:05PM
Exagen Inc. (Nasdaq: XGN), a leading provider of
autoimmune testing solutions, today announced its participation in
the 2023 Cantor Fitzgerald Global Healthcare Conference, which
takes place September 26-28, 2023, at the InterContinental Barclay
Hotel in New York City. John Aballi, Exagen’s President and Chief
Executive Officer and Kamal Adawi, Exagen’s Chief Financial
Officer, will participate in a panel discussion on Tuesday,
September 26th, at 8:45 AM ET. Interested parties may access the
webcast of the presentation using a link on Exagen’s website at
https://investors.exagen.com/events.
About Exagen Inc.
Exagen is a leading provider of autoimmune testing and its
purpose as an organization is to provide clarity in autoimmune
disease decision making with the goal of improving patients’
clinical outcomes. Exagen is located in San Diego County,
California.
For more information, please visit Exagen.com and
follow @ExagenInc on Twitter.
Investor RelationsExagen Inc. Ryan
Douglasrdouglas@exagen.com 760.560.1525
CompanyExagen Inc.Kamal Adawi, Chief Financial
Officerkadawi@exagen.com
Exagen (NASDAQ:XGN)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Exagen (NASDAQ:XGN)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024